ImpactRx, Inc. operates as a promotion research organization for the pharmaceutical industry in the United States. The company tracks and evaluates the impact of pharmaceutical promotions on the prescribing behavior of the physicians. Its ImpactRx technology enables to collect and process the information on the perceptions and activities of physicians, as well as allows pharmaceutical companies to diagnose and predict the efficiency and effectiveness of sales and marketing initiatives. The company structures its data into a range of syndicated and semi-custom products in the areas of brand management and market research, sales management, managed care marketing, and oncology sales and marketing to assist pharmaceutical and biotech enterprises in decision making. ImpactRx, Inc. was founded in 2000 and is headquartered in Mount Laurel, New Jersey.

Milestones
edit

ImpactRx added Liji Jinaraj as Vice President, Finance.

Posted 5/19/10 at 12:16pm
ImpactRx added Jill Mundinger Walton as Sr. VP, Business Development.

Posted 5/19/10 at 12:14pm
ImpactRx added Gerald J. Gallivan as Co-Founder and Director .

Posted 1/11/10 at 7:54pm
ImpactRx added Richard C. Altus as CEO.

Posted 1/11/10 at 7:54pm
ImpactRx received $1.2M in Series E funding. (1/11/10)

Posted 1/11/10 at 7:54pm via finsmes.com
ImpactRx acquired TargetRx. (9/13/11)

Posted 9/13/11 at 9:24pm via prnewswire.com
ImpactRx was acquired by Symphony Technology Group. (4/18/11)

Posted 4/18/11 at 7:53pm via freshnews.com